Brazil vs Western Sahara: Share of children with symptoms of a respiratory infection who received antibiotics
Brazil
51.4%
in 2018
Western Sahara
51.1%
in 2018
Brazil rank
65th
Western Sahara rank
66th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Brazil
- Western Sahara
How they compare
Brazil currently reports 51.4% against 51.1% in Western Sahara, a difference of 0.3%.
The two have swapped places 1 time across 19 shared years of data; in 2000 it was Western Sahara ahead.
Brazil ranks 65th and Western Sahara ranks 66th of 132 countries.
Western Sahara has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Western Sahara | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.6% | 52.9% | 4.3% | Western Sahara |
| 2010s | 50.5% | 53.7% | 3.2% | Western Sahara |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Brazil or Western Sahara?
- Brazil, at 51.4% against 51.1% in Western Sahara as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Brazil and Western Sahara?
- 0.3%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Western Sahara?
- 19 years are reported by both, from 2000 to 2018.
- How do Brazil and Western Sahara rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Brazil ranks 65th and Western Sahara ranks 66th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.